- Benuvia Operations and Mikart have entered a strategic co-marketing partnership to provide integrated services from API development to finished drug product manufacturing.
- The collaboration aims to streamline development timelines, enhance coordination, and expand access to controlled-substance expertise within a unified CDMO framework.
Benuvia Operations, LLC has entered into a strategic co-marketing partnership with Mikart, LLC to offer integrated services across drug substance development and finished drug product manufacturing. The agreement brings together Benuvia’s capabilities in controlled substances and complex APIs with Mikart’s expertise in formulation development, analytical testing, and finished dose manufacturing.
The partnership is designed to deliver end-to-end CDMO and contract manufacturing solutions for pharmaceutical and biotechnology companies. By combining their capabilities, the companies aim to streamline development timelines, improve coordination across functions, and provide a more unified service offering.
Under the agreement, Benuvia and Mikart will jointly promote their services globally and collaborate on business development activities. These efforts include shared customer engagements, coordinated presentations, participation in industry events, and targeted outreach to potential clients. The companies intend to leverage their respective networks to expand market reach and support growth.
The collaboration will initially focus on controlled substances, cannabinoids, and emerging therapeutic categories. Both companies stated that the combined technical, regulatory, and manufacturing expertise is intended to support customers seeking integrated solutions across the product lifecycle.
“Mikart’s strength in formulation and finished dose manufacturing complements our capabilities in small molecule API development and controlled substance manufacturing. Together, we offer customers a seamless, highly differentiated, U.S.-based CDMO solution that prioritizes quality, compliance, and speed to market.”
Terry Novak, Chief Executive Officer of Benuvia
